4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-032259
Chief Financial Officer sold 3,000 shares at $7.76 ($23,280)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jeanmonod Patrik Chief Financial Officer | 2023-05-24 | Sale 10b5-1 | −3,000 | $7.76 | $23,280 | 107,768 | D |
| Open-market sales · 3,000 sh · avg $7.76 · $23,280 | |||||||
Loading xslF345X04/doc4.xml…